October 05, 2008

TEVA PHARMACEUTICAL INDUSTRIES LTD. v. ASTRAZENECA PHARMACEUTICALS LP et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 30, 2012

    AstraZeneca Denied Attys' Fees Despite Crestor Patent Win

    AstraZeneca Pharmaceuticals LP can't get attorneys' fees from Teva Pharmaceutical Industries Ltd. despite winning a patent fight over AstraZeneca's blockbuster cholesterol drug Crestor, a Pennsylvania federal judge ruled Thursday, saying AstraZeneca hadn't sufficiently proved that Teva acted in bad faith.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!